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jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ jcc as eDetailed visualization of coronary stents during their posi-
tioning from live ﬂuoroscopic images is critical for successful
percutaneous coronary intervention (PCI). Coronary stent under-
expansion is a major contributor to in-stent restenosis and stent
thrombosis, even in the drug-eluting stent era [1,2]. Coronary
stent implantation is monitored by X-ray ﬂuoroscopy where
imaging quality of the guidewires, markers, and stent struts is
often low. Physicians are keen to know whether the stent is
located at precise desired lesion or whether the stent has
expanded properly against the vessel wall. However, they often
have difﬁcult situations making a precise judgement from live
ﬂuoroscopic images due to rapid motion of coronary arteries and
poor contrast.
The current gold standard for detection of stent under-expansion
is intravascular ultrasound (IVUS) [3] and optical coherence
tomography (OCT) [4,5]. IVUS and OCT improve adequate stent
expansion and decrease rates of target vessel revascularization
compared to conventional angiography. However, IVUS and OCT are
limited by cost, non-simultaneous assessments of stent deployment,
and procedural time.
The report by Biscaglia et al. [6] presents clinical examples of
enhanced stent visualization (ESV) during PCI in several clinical
situations and an overview of several articles on ESV. The
authors concluded that ESV systems can be utilized along
with or instead of intracoronary imaging techniques during
stent implantation, to assess stent expansion, overlapping, and
integrity.
ESV is an emerging method that relies on two balloon markers to
enable real-time enhanced visualization and detection of precise
positioning and expansion. A novel and robust image-based tracking
framework for image-guided intervention is proposed such that
physicians do not need manually to initialize the tracking [7]. ESV
systems provide a high quality and real-time ﬂuoroscopic assess-
ment during PCI.DOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.02.008
http://dx.doi.org/10.1016/j.jccase.2015.04.003
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resulting in deployed stents that are difﬁcult to visualize.
Motion-corrected X-ray stent visualization is a signiﬁcant
advance in X-ray technique that allows assessment of stent
expansion. Several systems have been developed as advanced
ﬂuoroscopic imaging alternatives to IVUS, superior to conven-
tional angiography alone for assessing stent deployments. These
include StentBoost Subtract system1 (Philips Healthcare, Best,
The Netherlands), 18-21, ClearStent Live system1 (Siemens
Healthcare, Munich, Germany), and StentViz1 (GE Healthcare,
Milwaukee, WI, USA) [8].
ESV is an excellent X-ray imaging modality that provides
enhanced sent visualization by eliminating motion artifact.
These systems are time-efﬁcient and cost-effective compared
to IVUS or OCT. It is important for physicians to assess the
precise stent location under real-time ﬂuoroscopy after obser-
vations of IVUS or OCT. However, there are few clinical or
outcome data for ESV techniques. IVUS or OCT remain the gold
standard for evaluation of adequate stent expansion, stent
overlapping, and stent integrity. However, ESV can be an
alternative or adjunctive and user-friendly tool in several
situations during PCI.
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